We are live on ! Find out more
Baillie Gifford & Co

Baillie Gifford & Co Portfolio holdings

AUM $110B
1-Year Est. Return 4.8%
 

Baillie Gifford & Co., founded in 1908 by Lt Col Augustus Baillie and Carlyle Gifford and headquartered in Edinburgh, Scotland, is an independent, partnership-owned investment management firm renowned for its long-term, growth-oriented approach, managing over £230 billion ($290 billion USD) in assets as of late 2024. Focusing primarily on global equities, the firm serves institutional clients like pension funds and retail investors through mutual funds and investment trusts, such as the Scottish Mortgage Investment Trust, emphasizing fundamental research into innovative, high-growth companies—often holding stakes in firms like Tesla and Amazon for decades. With around 2,000 employees across offices in London, New York, Hong Kong, and beyond, Baillie Gifford operates without external ownership pressures, allowing its 58 partners to prioritize patience and conviction over short-term market trends. Known for its low-profile culture and ESG integration, the firm has earned a reputation as a thoughtful, contrarian investor in a world of rapid-fire trading.

This Fund
S&P 500
This Quarter Est. Return
+0.02%
1 Year Est. Return
+4.8%
3 Year Est. Return
+123.53%
5 Year Est. Return
+125.55%
10 Year Est. Return
+1,754.37%
AUM
$182B
AUM Growth
-$8.9B
Cap. Flow
-$1.05B
Cap. Flow %
-0.58%
Top 10 Hldgs %
39.59%
Holding
518
New
26
Increased
181
Reduced
122
Closed
19

Top Sells

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$3.07B
2
YMM icon
Full Truck Alliance
YMM
+$1.57B
3
RMD icon
ResMed
RMD
+$715M
4
NVDA icon
NVIDIA
NVDA
+$647M
5
BABA icon
Alibaba
BABA
+$597M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 26.6%
2 Healthcare 23.23%
3 Technology 20.07%
4 Communication Services 12.81%
5 Financials 6.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GLW icon
351
Corning
GLW
$143B
$24K ﹤0.01%
+653
New +$24.5K
SLAB icon
352
Silicon Laboratories
SLAB
$7.23B
$24K ﹤0.01%
116
-11
-9% -$2.03K
TGT icon
353
Target
TGT
$68B
$24K ﹤0.01%
+105
New +$25.5K
TTC icon
354
Toro Company
TTC
$9.49B
$24K ﹤0.01%
245
SMAR
355
DELISTED
Smartsheet Inc.
SMAR
$24K ﹤0.01%
311
SPWR
356
DELISTED
SunPower Corporation Common Stock
SPWR
$24K ﹤0.01%
1,171
-98
-8% -$2.65K
GBT
357
DELISTED
Global Blood Therapeutics, Inc.
GBT
$24K ﹤0.01%
835
AZN icon
358
AstraZeneca
AZN
$250B
$23K ﹤0.01%
200
CHRS icon
359
Coherus Oncology
CHRS
$196M
$23K ﹤0.01%
1,431
-174
-11% -$3.04K
CRWD icon
360
CrowdStrike
CRWD
$218B
$23K ﹤0.01%
456
-44
-9% -$2.68K
HD icon
361
Home Depot
HD
$355B
$23K ﹤0.01%
56
MED icon
362
Medifast
MED
$141M
$23K ﹤0.01%
110
MNTV
363
DELISTED
Momentive Global Inc. Common Stock
MNTV
$23K ﹤0.01%
1,095
APTV icon
364
Aptiv
APTV
$10.3B
$22K ﹤0.01%
134
AVY icon
365
Avery Dennison
AVY
$13.4B
$22K ﹤0.01%
100
-10
-9% -$2.14K
DBX icon
366
Dropbox
DBX
$8.12B
$22K ﹤0.01%
881
EA
367
DELISTED
Electronic Arts
EA
$22K ﹤0.01%
+164
New +$22.1K
EXEL icon
368
Exelixis
EXEL
$13.4B
$22K ﹤0.01%
1,200
BCRX icon
369
BioCryst Pharmaceuticals
BCRX
$2.4B
$21K ﹤0.01%
1,500
JAZZ icon
370
Jazz Pharmaceuticals
JAZZ
$16.7B
$21K ﹤0.01%
+165
New +$21.7K
VRNT
371
DELISTED
Verint Systems
VRNT
$21K ﹤0.01%
395
ACN icon
372
Accenture
ACN
$108B
$20K ﹤0.01%
48
KWR icon
373
Quaker Houghton
KWR
$2.92B
$20K ﹤0.01%
86
LOGI icon
374
Logitech
LOGI
$15.2B
$20K ﹤0.01%
235
PGNY icon
375
Progyny
PGNY
$2.2B
$20K ﹤0.01%
396

Similar funds

Baillie Gifford & Co's Q4 2021 Portfolio in Review

As of Q4 2021, Baillie Gifford & Co held 518 positions worth $182B, down 4.7% from $191B the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Baillie Gifford & Co's Q4 2021 filing shows 26 new, 181 increased, 122 reduced and 19 closed positions. Its largest new stake was Charles Schwab: 7,506,268 shares worth $631M. The largest sale was Tesla, an estimated $3.07B.

By sector, the portfolio is most concentrated in Consumer Discretionary at 27% of assets, down from 28% a quarter earlier, followed by Healthcare and Technology.

  • Baillie Gifford & Co's largest Q4 2021 buy was Charles Schwab: 7,506,268 shares worth $631M.
  • Baillie Gifford & Co added most to Moderna in Q4 2021, an estimated $1.04B increase.
  • Baillie Gifford & Co's biggest Q4 2021 reduction was Tesla, cutting an estimated $3.07B.
  • Baillie Gifford & Co fully exited Autohome in Q4 2021, selling an estimated $140M.
  • Baillie Gifford & Co's ten largest holdings make up 40% of its $182B portfolio in Q4 2021.
  • Baillie Gifford & Co opened 26 new positions and closed 19 in Q4 2021.
  • Baillie Gifford & Co's portfolio value fell 4.7% quarter-over-quarter to $182B.

Based on Baillie Gifford & Co's 13F filing for Q4 2021, filed 20 Jan 2022.